Cargando…

Quality of life in children with tuberous sclerosis complex: A pediatric cohort study

AIMS: To evaluate the quality‐of‐life (QOL) impairment and identify the possible risk factors in patients with tuberous sclerosis complex (TSC) in China. METHODS: The parent proxy‐report PedsQL 4.0 Generic Core Scales were administered to 124 caregivers of children with TSC (aged 2‐18 years). For co...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Yifeng, Wang, Ji, Zhou, Yuanfeng, Yu, Lifei, Zhang, Linmei, Zhou, Shuizhen, Wang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871787/
https://www.ncbi.nlm.nih.gov/pubmed/33225634
http://dx.doi.org/10.1111/cns.13473
_version_ 1783649078082535424
author Ding, Yifeng
Wang, Ji
Zhou, Yuanfeng
Yu, Lifei
Zhang, Linmei
Zhou, Shuizhen
Wang, Yi
author_facet Ding, Yifeng
Wang, Ji
Zhou, Yuanfeng
Yu, Lifei
Zhang, Linmei
Zhou, Shuizhen
Wang, Yi
author_sort Ding, Yifeng
collection PubMed
description AIMS: To evaluate the quality‐of‐life (QOL) impairment and identify the possible risk factors in patients with tuberous sclerosis complex (TSC) in China. METHODS: The parent proxy‐report PedsQL 4.0 Generic Core Scales were administered to 124 caregivers of children with TSC (aged 2‐18 years). For comparison, the survey was also conducted in a demographically group‐matched sample of healthy controls (HCs) (aged 2‐18 years). RESULTS: A total of 124 children with TSC and 206 HCs were recruited. The mean parent proxy‐report total scale score, physical health summary score, and psychosocial health summary score for children with TSC were 65.0 (SD 19.7), 77.6 (SD 22.9), and 58.0 (SD 21.3), respectively, compared with the HC values of 83.6 (SD 14.3), 87.2 (SD 16.9), and 82.8 (SD 15.9). There were statistically significant differences between the two groups (P < .0001). TSC2 mutation (P = .033), epilepsy (P = .011), seizure before 2 years old (P = .001), course of epilepsy (more than 2 years) (P = .001), high reported seizure frequency (more than once a month) (HRSF) (P = .007), multiple antiepileptic drugs (≥2) (P = .002), intellectual disability (ID) (mild and moderate ID, P < .0001, and severe and profound ID, P < .0001), and TANDs (P < .0001) (ADHD, P = .004; agoraphobia, P = .007; and social anxiety disorder, P < .0001) were closely related to lower QOL scores. CONCLUSION: This study is the first large cohort study on QOL in children with TSC in China. The results of the PedsQL 4.0 indicated that the QOL of children with TSC is significantly lower than that of HCs. TSC2 mutation, epilepsy, early onset, long disease course and HRSF, ID, and TANDs are risk factors for poor QOL.
format Online
Article
Text
id pubmed-7871787
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78717872021-02-17 Quality of life in children with tuberous sclerosis complex: A pediatric cohort study Ding, Yifeng Wang, Ji Zhou, Yuanfeng Yu, Lifei Zhang, Linmei Zhou, Shuizhen Wang, Yi CNS Neurosci Ther Original Articles AIMS: To evaluate the quality‐of‐life (QOL) impairment and identify the possible risk factors in patients with tuberous sclerosis complex (TSC) in China. METHODS: The parent proxy‐report PedsQL 4.0 Generic Core Scales were administered to 124 caregivers of children with TSC (aged 2‐18 years). For comparison, the survey was also conducted in a demographically group‐matched sample of healthy controls (HCs) (aged 2‐18 years). RESULTS: A total of 124 children with TSC and 206 HCs were recruited. The mean parent proxy‐report total scale score, physical health summary score, and psychosocial health summary score for children with TSC were 65.0 (SD 19.7), 77.6 (SD 22.9), and 58.0 (SD 21.3), respectively, compared with the HC values of 83.6 (SD 14.3), 87.2 (SD 16.9), and 82.8 (SD 15.9). There were statistically significant differences between the two groups (P < .0001). TSC2 mutation (P = .033), epilepsy (P = .011), seizure before 2 years old (P = .001), course of epilepsy (more than 2 years) (P = .001), high reported seizure frequency (more than once a month) (HRSF) (P = .007), multiple antiepileptic drugs (≥2) (P = .002), intellectual disability (ID) (mild and moderate ID, P < .0001, and severe and profound ID, P < .0001), and TANDs (P < .0001) (ADHD, P = .004; agoraphobia, P = .007; and social anxiety disorder, P < .0001) were closely related to lower QOL scores. CONCLUSION: This study is the first large cohort study on QOL in children with TSC in China. The results of the PedsQL 4.0 indicated that the QOL of children with TSC is significantly lower than that of HCs. TSC2 mutation, epilepsy, early onset, long disease course and HRSF, ID, and TANDs are risk factors for poor QOL. John Wiley and Sons Inc. 2020-11-23 /pmc/articles/PMC7871787/ /pubmed/33225634 http://dx.doi.org/10.1111/cns.13473 Text en © 2020 The Authors. CNS Neuroscience & Therapeutics Published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Ding, Yifeng
Wang, Ji
Zhou, Yuanfeng
Yu, Lifei
Zhang, Linmei
Zhou, Shuizhen
Wang, Yi
Quality of life in children with tuberous sclerosis complex: A pediatric cohort study
title Quality of life in children with tuberous sclerosis complex: A pediatric cohort study
title_full Quality of life in children with tuberous sclerosis complex: A pediatric cohort study
title_fullStr Quality of life in children with tuberous sclerosis complex: A pediatric cohort study
title_full_unstemmed Quality of life in children with tuberous sclerosis complex: A pediatric cohort study
title_short Quality of life in children with tuberous sclerosis complex: A pediatric cohort study
title_sort quality of life in children with tuberous sclerosis complex: a pediatric cohort study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871787/
https://www.ncbi.nlm.nih.gov/pubmed/33225634
http://dx.doi.org/10.1111/cns.13473
work_keys_str_mv AT dingyifeng qualityoflifeinchildrenwithtuberoussclerosiscomplexapediatriccohortstudy
AT wangji qualityoflifeinchildrenwithtuberoussclerosiscomplexapediatriccohortstudy
AT zhouyuanfeng qualityoflifeinchildrenwithtuberoussclerosiscomplexapediatriccohortstudy
AT yulifei qualityoflifeinchildrenwithtuberoussclerosiscomplexapediatriccohortstudy
AT zhanglinmei qualityoflifeinchildrenwithtuberoussclerosiscomplexapediatriccohortstudy
AT zhoushuizhen qualityoflifeinchildrenwithtuberoussclerosiscomplexapediatriccohortstudy
AT wangyi qualityoflifeinchildrenwithtuberoussclerosiscomplexapediatriccohortstudy